GRDX β€” ENTERO THERAPEUTICS INC

Ownership history in UBS Group AG  Β·  2 quarters on record

This page tracks every 13F SEC filing in which UBS Group AG reported a position in ENTERO THERAPEUTICS INC (GRDX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

% of Fund (quarterly)    GRDX price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 2 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 536 +470 +712.1% 0.00% $2K $4.66
2025 Q3 INITIATED 66 β€” β€” 0.00% $330 $5.00

🏒 Other funds also holding GRDX

As of 2025 Q4 β€” sorted by position size

FNY Investment Advisers, LLC 3Y 7Y 0.04% DRW Securities, LLC 3Y 7Y 0.01% RENAISSANCE TECHNOLOGIES LLC 3Y 7Y 0.0% GEODE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% CITIGROUP INC 3Y 7Y 0.0% VANGUARD GROUP INC 3Y 7Y 0.0% OSAIC HOLDINGS, INC. 3Y 0.0% BANK OF AMERICA CORP /DE/ 3Y 7Y 0.0%
← Back to UBS Group AG Holdings